Clinical Trial Update: Nimotuzumab in Adults With Pancreatic Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicating nimotuzumab trials in adults with advanced or metastatic pancreatic cancer have completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Oncoscience AG | Conditions: Pancreatic Cancer, Advanced or Metastatic | Phase 2, Phase 3 | Status: COMPLETED